United States · Health Care startup
United States · OS Therapies
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
Funding reportedLast round: Debt financing
What company datasets say OS Therapies raised
Funding, as reported
Reported in all$7.0Min dollars
Rounds2
Last roundDebt financing
Last round dateJul 2021
Investors listed3
Founders and team
From OS Therapies's own website: 9 on the team.
- Anivive Animal HealthEdward Robb, DVM Chief Strategy Officer
- Gerald CommisiongChief Business Officer
- Jack DollChief of Staff
- Manhattan BioSciencesChris Benecchi Chief Business Officer
- Robert PetitChief Medical & Scientific Officer
- Karim GalzahrDirector
- Olivia Egge Osteosarcoma PatientOS Therapies, Director Emerita
- Osteosarcoma Patient AdvocacyOsteosarcoma Collaborative, Chair
- Paul RomnessChair
AdvisersDr. Craig EagleJutta Wanner
Health Care in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put OS Therapies in front of investors. Or tell us what we have wrong.